Innovative strategies for biotherapeutic developability assessment

Paris

4:00 PM (CEST)

Boston

10:00 AM (EDT)

San Francisco

7:00 AM (PDT)

About the event

Once a year, we host the Discngine Meetup event - a dynamic interdisciplinary gathering at the interface between science and IT in drug discovery. This year’s theme, “Innovative strategies for biotherapeutic developability assessment,” includes insightful talks and interactive sessions led by industry experts.

Predicting developability profiles of novel biotherapeutics can greatly de-risk projects, reduce timelines, and save resources. Our speakers will present early-stage approaches and innovative technologies for developability assessment. They will discuss in-silico workflows and advanced in-vitro methods that guide decision-making toward selecting the most optimal drug candidate.

By attending this two-hour virtual event, you will gain insights into effective strategies and solutions to address the ongoing challenges in this progressing field.

Norbert Furtmann

Group Leader & Head of AI Innovation NANOBODY® Platform at Sanofi

Per Greisen

President & Head of Protein Design at BioMap

Matthew Raybould

Postdoctoral Researcher in the Oxford Protein Informatics Group at University of Oxford

Essam Metwally

Principal Scientist / Scientific Director at Merck

Nels Thorsteinson

Director of Biologics at Chemical Computing Group

We will be hosting the final part of our event in Gather.Town, a unique virtual space!
With Gather, you will have the opportunity to navigate through a dynamic environment, where you can freely explore and engage with peers just as you would in a real-life setting.
We have tested this platform and are confident that Gather will provide you with an exceptional and immersive experience like no other. Get ready to enjoy a truly unique and interactive moment!